Save to Existing Project
Save to a New Project
Orpha Swiss GmbH
Opioid receptor antagonist reducing opioid induced respiratory depression...
MECHANISM OF ACTION
Competitive antagonist on opioid reptors. Inhibits opioid induced respiratory depression.
Strong Opioid-antagonist for postoperative use and in emergency after overdose of e.g. Heroine. Target groups are anaesthetists and hospitals (accident and emergency units). The product is a generic and supplied in packs of 10 ampoules.
Type of Business Relationship Sought
Country specific or regional distribution contract.
Last Updated Oct 2014
REGISTERED / FDA APPROVED / FINISHED PRODUCT